Filing Details
- Accession Number:
- 0001104659-24-025520
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-20 16:11:20
- Reporting Period:
- 2024-02-20
- Accepted Time:
- 2024-02-20 16:11:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1425205 | Iovance Biotherapeutics Inc. | IOVA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1423102 | P. Wayne Rothbaum | C/O Iovance Biotherapeutics, Inc. 825 Industrial Road, 4Th Floor San Carlos CA 94070 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-20 | 5,000,000 | $9.15 | 28,067,333 | No | 4 | P | Indirect | By Quogue Capital LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Quogue Capital LLC |
Footnotes
- Such shares may be held directly by Quogue Capital LLC or are held by one or more entities controlled by Quogue Capital LLC. The reporting person is the sole managing member of Quogue Capital LLC, and therefore, he is deemed to beneficially own such shares of common stock of the Issuer.
- The numbers reported in column 5 exclude 1,932,667 shares of common stock underlying 1,932,667 shares of Series B Preferred Stock of the Issuer beneficially owned by Quogue Capital LLC.
- Such shares purchased pursuant to Issuer's underwritten offering, which priced on 02/20/2024.
Billionaire Hedge Funds
